KEGG   DRUG: Cinpanemab
Entry
D11467                      Drug                                   
Name
Cinpanemab (USAN)
Formula
C6294H9744N1676O1990S46
Exact mass
142117.9945
Mol weight
142205.82
Sequence
(Heavy chain)
EVQLVESGGG LVEPGGSLRL SCAVSGFDFE KAWMSWVRQA PGQGLQWVAR IKSTADGGTT
SYAAPVEGRF IISRDDSRNM LYLQMNSLKT EDTAVYYCTS AHWGQGTLVT VSSASTKGPS
VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
VVTVPSSSLG TQTYICNVNH KPSNTKVDKR VEPKSCDKTH TCPPCPAPEL LGGPSVFLFP
PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS
VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS REEMTKNQVS
LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS
CSVMHEALHN HYTQKSLSLS PG
(Light chain)
SYELTQPPSV SVSPGQTARI TCSGEALPMQ FAHWYQQRPG KAPVIVVYKD SERPSGVPER
FSGSSSGTTA TLTITGVQAE DEADYYCQSP DSTNTYEVFG GGTKLTVLSQ PKAAPSVTLF
PPSSEELQAN KATLVCLISD FYPGAVTVAW KADSSPVKAG VETTTPSKQS NNKYAASSYL
SLTPEQWKSH RSYSCQVTHE GSTVEKTVAP TECS
(Disulfide bridge: H22-H98, H140-H196, H216-L213, H222-H'222, H225-H'225, H257-H37, H363-H421, H'22-H'98, H'140-H'196, H'216-L'213, H'257-H'317, H'363-H'421, L22-L87, L136-L195, L'22-L'87, L'136-L'195)
  Type
Peptide
Efficacy
Antiparkinsonian, Anti-synuclein alpha antibody
  Type
Monoclonal antibody
Comment
Treatment of Parkinson's disease
Target
SNCA [HSA:6622] [KO:K04528]
  Pathway
hsa05012  Parkinson disease
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    SNCA
     D11467  Cinpanemab (USAN)
Other DBs
CAS: 2094516-02-4
PubChem: 384585443
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system